A Selective Summary of Psychopharmacology Research Published in First Half of 2017

Balon R. Has psychopharmacology entered a blind alley? Ann Clin Psychiatry of J Am Acad Clin Psychiatr 2017; 29(3):157–8.

Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR. Serum allopregnanolone in women with postpartum “blues.†Obstet Gynecol 2001; 97(1):77–80.

Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 2017; doi: 10.1016/S0140-6736(17)31264-3.

Naeije G, Pepersack T. Delirium in elderly people. Lancet 2014; 383(9934):2044–5.

Su X, Meng Z-T, Wu X-H, Cui F, Li H-L, Wang D-X, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 2016; 388(10054):1893–902.

Cloud LJ, Zutshi D, Factor SA. Tardive dyskinesia: Therapeutic options for an increasingly common disorder. Neurotherapeutics 2014; 11(1):166–76.

Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, et al. KINECT 3: A phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry 2017; 174(5):476–84.